Boston University Clinical and Translational Science Institute

波士顿大学临床与转化科学研究所

• 批准号: 9126634
• 负责人: Darrell N. Kotton
• 金额: $ 56.84万
• 依托单位: BOSTON UNIVERSITY MEDICAL CAMPUS
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-08-13 至 2019-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9126634
• 关键词: Address; Adopted; Affinity; Area; Basic Science; Biological; Biomedical Engineering; Biomedical Research; Bone Regeneration; Boston; Cardiology; Clinical; Clinical Sciences; Collaborations; Dentistry; Dermatology; Development; Discipline; Doctor of Philosophy; Drug Delivery Systems; Educational Curriculum; Effectiveness; Environment; Faculty; Financial Support; Floor; Fostering; Foundations; Framingham Heart Study; Funding; Future; Gastroenterology; Geriatrics; Goals; Hematology; Home environment; Housing; Industry; Institutes; Institution; Intention; Interdisciplinary Study; International; Laboratories; Leadership; Learning; Marketing; Medical; Medicine; Mentors; Mission; Molecular Medicine; Orthopedics; Outcome; Patients; Pediatric Oncology; Pediatric Surgical Procedures; Performance; Peripheral; Pharmaceutical Preparations; Phenotype; Play; Positioning Attribute; Postdoctoral Fellow; Process; Productivity; Program Evaluation; Publications; Pulmonology; Regenerative Medicine; Research; Research Personnel; Research Training; Resources; Role; Science; Scientist; Secure; Shapes; Sickle Cell; Stem Cell Research; Stem cells; Students; Study Subject; TNFSF15 gene; Teaching Method; Technology; Time; Toxicity Tests; Training; Training Programs; Translational Research; Universities; Vision; Vocational Guidance; Workforce Development; base; bench to bedside; career; career development; cell bank; design; education research; efficacy testing; experience; foot; human disease; innovation; interdisciplinary approach; interest; medical schools; member; mid-career faculty; multidisciplinary; personalized medicine; physical science; pre-doctoral; programs; skills; success; teacher; tool; translational medicine

The overarching concepts and goals of the Regenerative Medicine Training Program (RMTP TL1) are to 1) provide an innovative, integrative and interdisciplinary training program for pre- doctoral and post-doctoral trainees which will leverage a unique and internationally recognized strength of BU, 2) establish an environment that facilitates translational team science interactions with trainees, MD scientists and clinicians, thereby synergistically bridging research strengths with interdisciplinary approaches in regenerative medicine, and 3) catapult BU into the forefront of institutions that are producing scientists with the skills and expertise to fulfill a current and future patient-based need for regenerative medicine. The objectives of our training program also align precisely with the general Boston University CTSI (BU CTSI) goals and with the strong emphasis on regenerative medicine at Boston University School of Medicine, as well as to further the mission of NCATS of expediting personalized medicine and the discovery and delivery of drugs to market. The RMTP will provide support for 3 pre-doctoral and 2 post- doctoral trainees each year, totaling 27 pre-doctoral and 18 post-doctoral trainees supported for the duration of the program, with each trainee participating for two years. Accepted trainees will be outstanding students/postdocs and selected based on grades/productivity, quality of the proposal, likely to pursue careers in academic regenerative medicine, highly motivated, energetic, and well-prepared for the curriculum. The curriculum will be competency-based and include rigorous training in didactic and laboratory based concepts and technology. An extensive and individualized mentoring plan will be implemented for each trainee that will included both scientific as well career development guidance. We fully anticipate that under the vision of “todays trainees are the teachers of tomorrow”, the RMTP will generate a continual influx of research and clinical leaders in the stem cell/regenerative medicine field who will make significant contributions resulting in the realization of its full medical potential. We seek to retain a major portion of our trainees, both in our own program and elsewhere, as investigators and mentors in regenerative medicine. Success of the RMTP will be based on the ability to increase the pipeline of well-trained scientists who continue their research in regenerative medicine, the number and quality of their publications, and leadership positions they assume in both industry and academic environments.

再生医学培训计划（RMTP）的总体概念和目标 TL1）到1）为预科提供创新，综合和跨学科的培训计划 博士和博士后学员将利用独特而国际认可的 BU的力量，2）建立一个促进转化团队科学的环境 与培训，医学博士和临床医生的互动，从而协同桥接研究 再生医学中跨学科方法的优势，以及3）弹射 机构的最前沿，这些机构正在生产具有技能和专业知识的科学家，以实现 当前和未来的基于患者的再生医学需求。我们培训的目标 计划还与波士顿将军CTSI（BU CTSI）的目标完全吻合，并与 波士顿大学医学院的重新强调再生医学 至于进一步加快个性化医学和发现的NCAT的使命 将药物送到市场。 RMTP将为3个前博士和2个后的支持提供支持。 每年的博士学员，共有27名博士后和18名博士后学员。 该计划的持续时间，每个学员参加了两年。接受的实习生会 成为杰出的学生/博士后，并根据成绩/生产力选择 提案，可能从事学术再生医学的职业，高度动机， 精力充沛，为课程做好准备。该课程将基于能力，并且 包括基于教学和实验室的概念和技术的严格培训。一个 每个学员将实施广泛而个性化的心理计划 包括科学以及职业发展指导。我们完全期望在 RMTP的愿景“今天的学员是明天的老师” 干细胞/再生医学领域的研究和临床领导者的涌入 大量贡献导致实现其全部医疗潜力。我们试图保留 我们的培训大部分地区，无论是在我们自己的计划还是其他地方，作为调查人员和 再生医学的导师。 RMTP的成功将基于增加的能力 训练有素的科学家的管道，他们继续研究再生医学， 他们出版物的数量和质量以及他们在这两个行业中的领导职务 和学术环境。